Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Growth (Status and Outlook) 2022-2028
- LP 4919373
- 85 Pages
- March 2022
- Pharmaceuticals
The United States Vascular Endothelial Growth Factor (VEGF) Inhibitors market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market, reaching US$ million by the year 2028. As for the Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vascular Endothelial Growth Factor (VEGF) Inhibitors players cover Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, and Regeneron Pharmaceuticals Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Endothelial Growth Factor (VEGF) Inhibitors market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
VEGF-A Inhibitor
VEGF-B Inhibitor
VEGF-C Inhibitor
VEGF-D Inhibitor
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Oncology
Ophthalmology
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Sanofi.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2017-2028
2.1.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Type
2.2.1 VEGF-A Inhibitor
2.2.2 VEGF-B Inhibitor
2.2.3 VEGF-C Inhibitor
2.2.4 VEGF-D Inhibitor
2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
2.3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2017-2022)
2.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Application
2.4.1 Oncology
2.4.2 Ophthalmology
2.5 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
2.5.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2017-2022)
3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Player
3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Players
3.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Players (2020-2022)
3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Players (2020-2022)
3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vascular Endothelial Growth Factor (VEGF) Inhibitors by Regions
4.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (2017-2022)
4.2 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2017-2022)
4.3 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2017-2022)
4.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2017-2022)
4.5 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2017-2022)
5 Americas
5.1 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2017-2022)
5.2 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022)
5.3 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2017-2022)
6.2 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022)
6.3 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors by Country (2017-2022)
7.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022)
7.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors by Region (2017-2022)
8.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022)
8.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Regions (2023-2028)
10.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Regions (2023-2028)
10.1.2 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.1.3 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.1.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.1.5 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.2 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Country (2023-2028)
10.2.1 United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.2.2 Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.2.3 Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.2.4 Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.3 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Region (2023-2028)
10.3.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.3.2 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.3.3 Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.3.4 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.3.5 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.3.6 Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Country (2023-2028)
10.4.1 Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.4.2 France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.4.3 UK Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.4.4 Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.4.5 Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.5 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Region (2023-2028)
10.5.1 Egypt Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.5.2 South Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.5.3 Israel Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.5.4 Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.5.5 GCC Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
10.6 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Type (2023-2028)
10.7 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer AG
11.1.1 Bayer AG Company Information
11.1.2 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
11.1.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer AG Main Business Overview
11.1.5 Bayer AG Latest Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Information
11.2.2 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
11.2.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
11.3.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Regeneron Pharmaceuticals Inc.
11.4.1 Regeneron Pharmaceuticals Inc. Company Information
11.4.2 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
11.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Regeneron Pharmaceuticals Inc. Main Business Overview
11.4.5 Regeneron Pharmaceuticals Inc. Latest Developments
11.5 Sanofi.
11.5.1 Sanofi. Company Information
11.5.2 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
11.5.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi. Main Business Overview
11.5.5 Sanofi. Latest Developments
12 Research Findings and Conclusion
Table 1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of VEGF-A Inhibitor
Table 3. Major Players of VEGF-B Inhibitor
Table 4. Major Players of VEGF-C Inhibitor
Table 5. Major Players of VEGF-D Inhibitor
Table 6. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2017-2022)
Table 9. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2017-2022)
Table 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Player (2020-2022)
Table 14. Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Products Offered
Table 15. Vascular Endothelial Growth Factor (VEGF) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Regions (2017-2022)
Table 20. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Country (2017-2022)
Table 22. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2017-2022)
Table 24. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2017-2022)
Table 26. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region (2017-2022)
Table 28. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2017-2022)
Table 30. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2017-2022)
Table 32. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Country (2017-2022)
Table 34. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2017-2022)
Table 36. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 45. Key Market Challenges & Risks of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 46. Key Industry Trends of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 47. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share Forecast by Application (2023-2028)
Table 53. Bayer AG Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 54. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 55. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Bayer AG Main Business
Table 57. Bayer AG Latest Developments
Table 58. F. Hoffmann-La Roche Ltd. Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 59. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 60. F. Hoffmann-La Roche Ltd. Main Business
Table 61. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. F. Hoffmann-La Roche Ltd. Latest Developments
Table 63. Novartis AG Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 64. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 65. Novartis AG Main Business
Table 66. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Novartis AG Latest Developments
Table 68. Regeneron Pharmaceuticals Inc. Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 69. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 70. Regeneron Pharmaceuticals Inc. Main Business
Table 71. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Regeneron Pharmaceuticals Inc. Latest Developments
Table 73. Sanofi. Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 74. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 75. Sanofi. Main Business
Table 76. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Sanofi. Latest Developments
List of Figures
Figure 1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type in 2021
Figure 7. Vascular Endothelial Growth Factor (VEGF) Inhibitors in Oncology
Figure 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Oncology (2017-2022) & ($ Millions)
Figure 9. Vascular Endothelial Growth Factor (VEGF) Inhibitors in Ophthalmology
Figure 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Ophthalmology (2017-2022) & ($ Millions)
Figure 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application in 2021
Figure 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Player in 2021
Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2017-2022 ($ Millions)
Figure 15. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2017-2022 ($ Millions)
Figure 16. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2017-2022 ($ Millions)
Figure 18. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Value Market Share by Country in 2021
Figure 19. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Market Share by Type in 2021
Figure 20. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application in 2021
Figure 21. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region in 2021
Figure 26. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application in 2021
Figure 27. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Country in 2021
Figure 34. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type in 2021
Figure 35. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application in 2021
Figure 36. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application in 2021
Figure 44. Egypt Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 50. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 51. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 53. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 54. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 57. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 58. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 59. Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 61. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 62. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 63. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 64. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 65. UK Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 66. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 67. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 68. Spain Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 71. Israel Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
